Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.81 |
| ▸ | NPC1 | O15118 | 5/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.68 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.68 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.68 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.64 |
| ▸ | RELA | Q04206 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | NT5E | P21589 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10192061 | 1.00 | RAB9A (0.81) | RAB9ANPC1SMN1; SMN2PTGS2MAPT | |
| SCHEMBL14580374 | 0.90 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL15214321 | 0.90 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL611657 | 0.90 | NPC1 (0.76) | RAB9ANPC1SMN1; SMN2PTGS2MAPT | |
| SCHEMBL9767723 | 0.90 | NPC1 (0.76) | RAB9ANPC1SMN1; SMN2PTGS2MAPT | |
| SCHEMBL10939703 | 0.90 | NPC1 (0.76) | RAB9ANPC1SMN1; SMN2PTGS2MAPT | |
| SCHEMBL27181403 | 0.90 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL822378 | 0.90 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL12310125 | 0.90 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL12959541 | 0.88 | KCNK3 (0.64) | RAB9ANPC1SMN1; SMN2PTGS2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0751123-B1 | Method for producing alkylsulfinylbenzamides | SUMITOMO SEIKA CHEMICALS (JP) | 2000-05-10 | — | — | EP | claimed |
| US-5672751-A | TREATMENT OF A HALOBENZAMIDE WITH AN ALKANETHIOL IN THE PRESENCE OF A PHASE TRANSFER CATALYST | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1997-09-30 | — | — | US | claimed |
| EP-0751123-A2 | Method for producing alkylsulfinylbenzamides | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1997-01-02 | — | — | EP | claimed |
| EP-0620122-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1996-03-13 | — | — | EP | claimed |
| US-5446010-A | Substrate sheet, thermosensitive colored image forming layer containing colorless dye precursor, binder, color developing agent having sulfonylureido group, aromatic amide sensitizer; storage stability | NEW OJI PAPER CO., LTD. (JP) | 1995-08-29 | — | — | US | claimed |
| EP-0657438-A2 | Method for producing alkylsulfinylbenzamides and 1,2-benzisothiazol-3-ones | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1995-06-14 | — | — | EP | claimed |
| EP-0620122-A1 | Thermosensitive recording material | NEW OJI PAPER CO., LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| JP-9123597-A | — | — | None | — | — | JP | disclosed |
| EP-3822253-A1 | METHOD FOR PREPARING PROPANEDINITRILE OXIME ETHER COMPOUND AND INTERMEDIATE COMPOUND | Shenyang Sinochem Agrochemicals R&D Co., Ltd. (CN) | 2021-05-19 | — | — | EP | disclosed |
| CN-111302967-A | Preparation method of N-aryl amide compound | 广东石油化工学院 | 2020-06-19 | — | — | CN | disclosed |
| US-9321766-B1 | Kinase inhibitors | ALLERGAN, INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20160096832-A1 | KINASE INHIBITORS | ALLERGAN, INC. | 2016-04-07 | — | — | US | disclosed |
| US-8106051-B2 | 4-Chloro-N-(4-tolyl)benzamide; to enhance the serum level of apoAI | SHIONOGI & CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| JP-H09123597-A | THERMAL RECORDING MATERIAL | RICOH CO LTD | 1997-05-13 | — | — | JP | disclosed |
| EP-0751123-A2 | Method for producing alkylsulfinylbenzamides | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5508416-A | HALOGENATING A 2-(ALKYLTHIO)BENZAMIDE, CYCLIZATION TO HETERO RING AND N-S LINKAGE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1996-04-16 | — | — | US | disclosed |
| EP-0620122-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1996-03-13 | — | — | EP | disclosed |
| US-5446010-A | Substrate sheet, thermosensitive colored image forming layer containing colorless dye precursor, binder, color developing agent having sulfonylureido group, aromatic amide sensitizer; storage stability | NEW OJI PAPER CO., LTD. (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0657438-A2 | Method for producing alkylsulfinylbenzamides and 1,2-benzisothiazol-3-ones | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1995-06-14 | — | — | EP | disclosed |
| EP-0620122-A1 | Thermosensitive recording material | NEW OJI PAPER CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096832-A1 | KINASE INHIBITORS | ABL1, LCK, ERBB2 | RAB9A 2799/4885NPC1 4204/4885SMN1; SMN2 4664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.